NFKB1 and melanoma: Based on this assumption, it has recently been shown that the downregulation of miR-146a observed in six melanoma cell lines with acquired resistance and in two lines derived from drug-resistant tumors could be considered an epigenetic mechanism involved in the maintenance of the high level of NF-κB associated to target therapy resistance due to its negative regulation of this transcription factor [185].